Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates

References

• M. Prince, A. Wimo, M. Guerchet, G.-C. Ali, Y.-T. Wu, M. Prina. World Alzheimer report 2015. The global impact of dementia, Alzheimer’s Disease International, London, UK. Available at http://www.worldalzreport2015.org/.
   Google Scholar
• L.E. Hebert, J. Weuve, P.A. Scherr, D.A. Evans. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census, Neurology 7(2013). pp. 1778–1783.
   Google Scholar
• E.K. Perry, R.H. Perry, C.J. Smith, D. Purohit, J. Bonham, D.J. Dick, J.M. Candy, J.A. Edwardson, and A. Fairbairn, Cholinergic receptors in cognitive disorders, Can. J. Neurol. Sci. 13 (1986), pp. 521–527.
   PubMed Web of Science ®Google Scholar
• H.C. Fibiger, Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence, Trends Neurosci. 14 (1991), pp. 220–223.
   PubMed Web of Science ®Google Scholar
• D. Paterson and A. Nordberg, Neuronal nicotinic receptors in the human brain, Prog. Neurobiol. 61 (2000), pp. 75–111.
   PubMed Web of Science ®Google Scholar
• E. Perry, C. Martin-Ruiz, M. Lee, M. Griffiths, M. Johnson, M. Piggott, V. Haroutunian, J.D. Buxbaum, J. Nasland, K. Davis, C. Gotti, F. Clementi, S. Tzartos, O. Cohen, H. Soreq, E. Jaros, R. Perry, C. Ballard, I. McKeith, and J. Court, Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases, Eur. J. Pharmacol. 393 (2000), pp. 215–222.
   PubMed Web of Science ®Google Scholar
• R.T. Mott and C.M. Hulette, Neuropathology of Alzheimer’s disease, Neuroimaging Clin. N. Am. 15 (2005), pp. 755–765, ix.
   PubMed Web of Science ®Google Scholar
• F. Assal and J.L. Cummings, Neuropsychiatric symptoms in the dementias, Curr. Opin. Neurol. 15 (2002), pp. 445–450.
   PubMed Web of Science ®Google Scholar
• T. Erkinjuntti, Treatment options: The latest evidence with galantamine (Reminyl), J. Neurol. Sci. 203–204 (2002), pp. 125–130.
   PubMed Web of Science ®Google Scholar
• T. Saito, Y. Takaki, N. Iwata, J. Trojanowski, and T.C. Saido, Alzheimer’s disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism, Sci. Aging Knowledge Environ. 2003 (2003), p. Pe1.
   PubMedGoogle Scholar
• P. Kasa, Z. Rakonczay, and K. Gulya, The cholinergic system in Alzheimer’s disease, Prog. Neurobiol. 52 (1997), pp. 511–535.
   PubMed Web of Science ®Google Scholar
• S.K. Mencher and L.G. Wang, Promiscuous drugs compared to selective drugs (promiscuity can be a virtue), BMC Clin. Pharmacol. 5 (2005), p. 3.
   PubMedGoogle Scholar
• F. Li, J.J. Wu, J. Wang, X.L. Yang, P. Cai, Q.H. Liu, L.Y. Kong, and X.B. Wang, Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer’s disease, Bioorg. Med. Chem. 25 (2017), pp. 3815–3826.
   PubMed Web of Science ®Google Scholar
• S.A. Nisha and K.P. Devi, Gelidiella acerosa protects against Abeta 25–35-induced toxicity and memory impairment in Swiss Albino mice: An in vivo report, Pharm. Biol. 55 (2017), pp. 1423–1435.
   PubMed Web of Science ®Google Scholar
• P. Riederer, W. Danielczyk, and E. Grunblatt, Monoamine oxidase-B inhibition in Alzheimer’s disease, Neurotoxicology 25 (2004), pp. 271–277.
   PubMed Web of Science ®Google Scholar
• D. Kim, S.H. Baik, S. Kang, S.W. Cho, J. Bae, M.Y. Cha, M.J. Sailor, I. Mook-Jung, and K.H. Ahn, Close correlation of monoamine oxidase activity with progress of Alzheimer’s disease in mice, observed by in vivo two-photon imaging, ACS Cent. Sci. 2 (2016), pp. 967–975.
   PubMed Web of Science ®Google Scholar
• N.T. Tzvetkov and L. Antonov, Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: Indications of iron binding, experimental evidence for optimised solubility and brain penetration, J. Enzyme Inhib. Med. Chem. 32 (2017), pp. 960–967.
   PubMed Web of Science ®Google Scholar
• R. Harada, A. Ishiki, H. Kai, N. Sato, K. Furukawa, S. Furumoto, T. Tago, N. Tomita, S. Watanuki, K. Hiraoka, Y. Ishikawa, Y. Funaki, T. Nakamura, T. Yoshikawa, R. Iwata, M. Tashiro, H. Sasano, T. Kitamoto, K. Yanai, H. Arai, Y. Kudo, and N. Okamura, Correlations of 18F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer’s disease, J. Nucl. Med. 117 (2017), p. 197426.
   Google Scholar
• C. Binda, J. Wang, L. Pisani, C. Caccia, A. Carotti, P. Salvati, D.E. Edmondson, and A. Mattevi, Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs, J. Med. Chem. 50 (2007), pp. 5848–5852.
   PubMed Web of Science ®Google Scholar
• Protein Data Bank, 2V61 Structure of human MAO B in complex with the selective inhibitor 7-(3- chlorobenzyloxy)-4-(methylamino)methyl-coumarin. Available at http://www.rcsb.org/pdb/explore/explore.do?structureId=2V61.
   Google Scholar
• J. Cheung, M.J. Rudolph, F. Burshteyn, M.S. Cassidy, E.N. Gary, J. Love, M.C. Franklin, and J.J. Height, Structures of human acetylcholinesterase in complex with pharmacologically important ligands, J. Med. Chem. 55 (2012), pp. 10282–10286.
   PubMed Web of Science ®Google Scholar
• Protein Data Bank, 4EY7 Crystal structure of recombinant human acetylcholinesterase in complex with Donepezil. Available at http://www.rcsb.org/pdb/explore/explore.do?structureId=4EY7.
   Google Scholar
• N.C. Inestrosa, A. Alvarez, C.A. Perez, R.D. Moreno, M. Vicente, C. Linker, O.I. Casanueva, C. Soto, and J. Garrido, Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer’s fibrils: Possible role of the peripheral site of the enzyme, Neuron 16 (1996), pp. 881–891.
   PubMed Web of Science ®Google Scholar
• C. Garino, T. Tomita, N. Pietrancosta, Y. Laras, R. Rosas, G. Herbette, B. Maigret, G. Quelever, T. Iwatsubo, and J.L. Kraus, Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays, J. Med. Chem. 49 (2006), pp. 4275–4285.
   PubMed Web of Science ®Google Scholar
• L. Yang, Q. Yang, K. Zhang, Y.J. Li, Y.M. Wu, S.B. Liu, L.H. Zheng, and M.G. Zhao, Neuroprotective effects of daphnetin against NMDA receptor-mediated excitotoxicity, Molecules 19 (2014), pp. 14542–14555.
   PubMed Web of Science ®Google Scholar
• E.C. Pereira, D.L. Lucetti, J.M. Barbosa-Filho, E.M. de Brito, V.S. Monteiro, M.C. Patrocinio, R.R. de Moura, L.K. Leal, D.S. Macedo, F.C. de Sousa, G.S. de Barros Viana, and S.M. Vasconcelos, Coumarin effects on amino acid levels in mice prefrontal cortex and hippocampus, Neurosci. Lett. 454 (2009), pp. 139–142.
   PubMed Web of Science ®Google Scholar
• A. Hornick, A. Lieb, N.P. Vo, J.M. Rollinger, H. Stuppner, and H. Prast, The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory, Neuroscience 197 (2011), pp. 280–292.
   PubMed Web of Science ®Google Scholar
• D. Oehlrich, F.J. Rombouts, D. Berthelot, F.P. Bischoff, M.A. De Cleyn, L. Jaroskova, G. Macdonald, M. Mercken, M. Surkyn, A.A. Trabanco, G. Tresadern, S. Van Brandt, A.I. Velter, T. Wu, and H.J. Gijsen, Design and synthesis of bicyclic heterocycles as potent gamma-secretase modulators, Bioorg. Med. Chem. Lett. 23 (2013), pp. 4794–4800.
   PubMed Web of Science ®Google Scholar
• J. Close, R. Heidebrecht Jr, J. Hendrix, C. Li, B. Munoz, L. Surdi, S. Kattar, P. Tempest, P. Moses, X. Geng, B. Hughes, N. Smotrov, C. Moxham, J. Chapnick, I. Kariv, G. Nikov, J.E. Burke, S. Deshmukh, V. Jeliazkova-Mecheva, J.K. Leach, D. Diaz, L. Xu, Z. Yang, G. Kwei, L. Moy, S. Shah, F. Tanga, C. Kenefic, D. Savage, M. Shearman, R.G. Ball, M.J. McNevin, A. Markarewicz, and T. Miller, Lead optimization of 4,4-biaryl piperidine amides as gamma-secretase inhibitors, Bioorg. Med. Chem. Lett. 22 (2012), pp. 3203–3207.
   PubMed Web of Science ®Google Scholar
• M.D. McBriar, J.W. Clader, I. Chu, R.A. Del Vecchio, L. Favreau, W.J. Greenlee, L.A. Hyde, A.A. Nomeir, E.M. Parker, D.A. Pissarnitski, L. Song, L. Zhang, and Z. Zhao, Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active gamma-secretase inhibitors, Bioorg. Med. Chem. Lett. 18 (2008), pp. 215–219.
   PubMed Web of Science ®Google Scholar
• H. Li, T. Asberom, T.A. Bara, J.W. Clader, W.J. Greenlee, H.B. Josien, M.D. McBriar, A. Nomeir, D.A. Pissarnitski, M. Rajagopalan, R. Xu, Z. Zhao, L. Song, and L. Zhang, Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors, Bioorg. Med. Chem. Lett. 17 (2007), pp. 6290–6294.
   PubMed Web of Science ®Google Scholar
• H. Josien, T. Bara, M. Rajagopalan, T. Asberom, J.W. Clader, L. Favreau, W.J. Greenlee, L.A. Hyde, A.A. Nomeir, E.M. Parker, D.A. Pissarnitski, L. Song, G.T. Wong, L. Zhang, Q. Zhang, and Z. Zhao, Small conformationally restricted piperidine N-arylsulfonamides as orally active gamma-secretase inhibitors, Bioorg. Med. Chem. Lett. 17 (2007), pp. 5330–5335.
   PubMed Web of Science ®Google Scholar
• Y.E. Kwon, J.Y. Park, K.T. No, J.H. Shin, S.K. Lee, J.S. Eun, J.H. Yang, T.Y. Shin, D.K. Kim, B.S. Chae, J.Y. Leem, and K.H. Kim, Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer’s disease therapeutics, Bioorg. Med. Chem. 15 (2007), pp. 6596–6607.
   PubMed Web of Science ®Google Scholar
• H.R. Girisha, J.N. Narendra Sharath Chandra, S. Boppana, M. Malviya, C.T. Sadashiva, and K.S. Rangappa, Active site directed docking studies: Synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase, Eur. J. Med. Chem. 44 (2009), pp. 4057–4062.
   PubMed Web of Science ®Google Scholar
• F.C. Meng, F. Mao, W.J. Shan, F. Qin, L. Huang, and X.S. Li, Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents, Bioorg. Med. Chem. Lett. 22 (2012), pp. 4462–4466.
   PubMed Web of Science ®Google Scholar
• M.R. Jones, E.L. Service, J.R. Thompson, M.C. Wang, I.J. Kimsey, A.S. DeToma, A. Ramamoorthy, M.H. Lim, T. Storr, Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-beta aggregation, Metallomics 4 (2012), pp. 910–920.
   PubMed Web of Science ®Google Scholar
• B. Klajnert, T. Wasiak, M. Ionov, M. Fernandez-Villamarin, A. Sousa-Herves, J. Correa, R. Riguera, and E. Fernandez-Megia, Dendrimers reduce toxicity of Aβ 1–28 peptide during aggregation and accelerate fibril formation, Nanomedicine 8 (2012), pp. 1372–1378.
   PubMed Web of Science ®Google Scholar
• M. Malviya, Y.C. Kumar, R.B. Mythri, C. Venkateshappa, M.N. Subhash, and K.S. Rangappa, Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer’s presenile dementia models, Bioorg. Med. Chem. 17 (2009), pp. 5526–5534.
   PubMed Web of Science ®Google Scholar
• Y.C. Kumar, M. Malviya, J.N. Chandra, C.T. Sadashiva, C.S. Kumar, S.B. Prasad, D.S. Prasanna, M.N. Subhash, and K.S. Rangappa, Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer’s dementia models, Bioorg. Med. Chem. 16 (2008), pp. 5157–5163.
   PubMed Web of Science ®Google Scholar
• V. Jeyachandran, R.R. Kumar, M.A. Ali, and T.S. Choon, A one-pot domino synthesis and discovery of highly functionalized dihydrobenzo[b]thiophenes as AChE inhibitors, Bioorg. Med. Chem. Lett. 23 (2013), pp. 2101–2105.
   PubMed Web of Science ®Google Scholar
• S.B. Bharate, L. Guo, T.E. Reeves, D.M. Cerasoli, and C.M. Thompson, New series of monoquaternary pyridinium oximes: Synthesis and reactivation potency for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase, Bioorg. Med. Chem. Lett. 19 (2009), pp. 5101–5104.
   PubMed Web of Science ®Google Scholar
• M. Pietsch and M. Gutschow, Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition, J. Med. Chem. 48 (2005), pp. 8270–8288.
   PubMed Web of Science ®Google Scholar
• L. Iuliano, A. Pacelli, M. Ciacciarelli, C. Zerbinati, S. Fagioli, F. Piras, M.D. Orfei, P. Bossu, F. Pazzelli, G. Serviddio, C. Caltagirone, and G. Spalletta, Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer’s disease, J. Alzheimers Dis. 36 (2013), pp. 545–553.
   PubMed Web of Science ®Google Scholar
• Y. Okada and M. Okada, Protective effects of plant seed extracts against amyloid beta-induced neurotoxicity in cultured hippocampal neurons, J. Pharm. Bioallied Sci. 5 (2013), pp. 141–147.
   PubMedGoogle Scholar
• R. Cecilia, U. Kunz, and T. Turek, Possibilities of process intensification using microwaves applied to catalytic microreactors, Chem. Engin. Process. Process Intensif. 46 (2007), pp. 870–881.
   Web of Science ®Google Scholar
• M. Nuchter, B. Ondruschka, W. Bonrath, and A. Gum, Microwave assisted synthesis – A critical technology overview, Green Chem. 6 (2004), pp. 128–141.
   Web of Science ®Google Scholar
• H. Weissbach, T.E. Smith, J.W. Daly, B. Witkop, and S. Udenfriend, A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine, J. Biol. Chem. 235 (1960), pp. 1160–1163.
   PubMed Web of Science ®Google Scholar
• L. Novaroli, M. Reist, E. Favre, A. Carotti, M. Catto, and P.A. Carrupt, Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening, Bioorg. Med. Chem. 13 (2005), pp. 6212–6217.
   PubMed Web of Science ®Google Scholar
• L.J. Legoabe, A. Petzer, and J.P. Petzer, alpha-Tetralone derivatives as inhibitors of monoamine oxidase, Bioorg. Med. Chem. Lett. 24 (2014), pp. 2758–2763.
   PubMed Web of Science ®Google Scholar
• M.J. Matos, C. Teran, Y. Perez-Castillo, E. Uriarte, L. Santana, and D. Vina, Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors, J. Med. Chem. 54 (2011), pp. 7127–7137.
   PubMed Web of Science ®Google Scholar
• S.Y. Kang, K.Y. Lee, S.H. Sung, M.J. Park, and Y.C. Kim, Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: Structure–activity relationships, J. Nat. Prod. 64 (2001), pp. 683–685.
   PubMed Web of Science ®Google Scholar
• G.L. Ellman, K.D. Courtney, V. Andres Jr, and R.M. Feather-Stone, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol. 7 (1961), pp. 88–95.
   PubMed Web of Science ®Google Scholar
• M.A. Akyüz, S.S. Erdem, and D.E. Edmondson, The aromatic cage in the active site of monoamine oxidase B: Effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine, J. Neural. Transm. (Vienna) 114 (2007), pp. 693–698.
   PubMed Web of Science ®Google Scholar